Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery

被引:13
作者
Feldmann, Christina [1 ,3 ]
Zayat, Rashad [2 ]
Goetzenich, Andreas [2 ]
Aljalloud, Ali [2 ]
Woelke, Eva [1 ]
Maas, Judith [1 ]
Tewarie, Lachmandath [2 ]
Schmitz-Rode, Thomas [1 ]
Autschbach, Ruediger [2 ]
Steinseifer, Ulrich [1 ]
Moza, Ajay [2 ]
机构
[1] Rhein Westfal TH Aachen, Inst Appl Med Engn, Helmholtz Inst, Dept Cardiovasc Engn, Aachen, Germany
[2] Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany
[3] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Hannover, Germany
来源
PLOS ONE | 2017年 / 12卷 / 02期
关键词
VENTRICULAR ASSIST DEVICE; CONTINUOUS-FLOW; AORTIC-STENOSIS; ADVERSE EVENTS; DISEASE; TRANSPLANTATION; RISTOCETIN; THERAPY; BRIDGE; CENTRIFUGAL;
D O I
10.1371/journal.pone.0171029
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Acquired von Willebrand syndrome (AvWS) is associated with postoperative bleeding complications in patients with continuous flow left ventricular assist devices (CF-LVADs). The aim of this study is to analyze the perioperative vWF profile comparing an axial pump (HMII) to a centrifugal pump (HVAD) regarding the correlation between perioperative occurrence of AvWS, early-and late-postoperative bleeding events. Methods From July 2013 until March 2015 blood samples of 33 patients (12 HMII/8 HVAD/13 controls) were prospectively collected at 12 different time points and analyzed for the vWF antigen (vWF: Ag), its activity (vWF: Ac) and the vWF: Ac/vWF: Ag-ratio (vWF: ratio). The follow up period for postoperative bleeding events was from July 2013 until July 2016. Results Postoperatively, there was no difference in the vWF-profile between HVAD and HMII groups. However, a subgroup of patients already had significantly lower vWF: ratios preoperatively. Postoperatively, both CF-LVAD groups presented significantly lower vWF: ratios compared to the control group. Bleeding events per patient-year did not differ between the two groups (HMII vs. HVAD: 0.67 vs. 0.85, p = 0.685). We detected a correlation between vWF: ratio < 0.7at LVAD-start (r = -0.583, p = 0.006) or at the end of surgery (r = -0.461, p = 0.035) and the occurrence of pericardial tamponade. In the control group, the drop in both vWF: Ag and vWF: Ac recovered immediately postoperatively above preoperative values. Conclusion A subgroup of patients with end-stage heart failure already suffers AvWS preoperatively. In both CF-LVAD groups, AvWS begins immediately after surgery. Intraoperative vWF: ratios < 0.7 correlate with higher incidences of pericardial tamponade and re-operation. The presumably dilutive effect of the heart lung machine on vWF vanishes immediately at the end of surgery, possibly as part of an acute-phase response.
引用
收藏
页数:17
相关论文
共 39 条
  • [1] Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
    Aaronson, Keith D.
    Slaughter, Mark S.
    Miller, Leslie W.
    McGee, Edwin C.
    Cotts, William G.
    Acker, Michael A.
    Jessup, Mariell L.
    Gregoric, Igor D.
    Loyalka, Pranav
    Frazier, O. H.
    Jeevanandam, Valluvan
    Anderson, Allen S.
    Kormos, Robert L.
    Teuteberg, Jeffrey J.
    Levy, Wayne C.
    Naftel, David C.
    Bittman, Richard M.
    Pagani, Francis D.
    Hathaway, David R.
    Boyce, Steven W.
    [J]. CIRCULATION, 2012, 125 (25) : 3191 - +
  • [2] Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis
    Baldauf, C.
    Schneppenheim, R.
    Stacklies, W.
    Obser, T.
    Pieconka, A.
    Schneppenheim, S.
    Budde, U.
    Zhou, J.
    Graeter, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (12) : 2096 - 2105
  • [3] Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis
    Chin, BSP
    Conway, DSG
    Chung, NAY
    Blann, AD
    Gibbs, CR
    Lip, GYH
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (06) : 515 - 521
  • [4] Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients
    Crow, Sheri
    Chen, Dong
    Milano, Carmelo
    Thomas, William
    Joyce, Lyle
    Piacentino, Valentino, III
    Sharma, Riti
    Wu, Jogin
    Arepally, Gowthami
    Bowles, Dawn
    Rogers, Joseph
    Villamizar-Ortiz, Nestor
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (04) : 1263 - 1269
  • [5] Establishing a Method for In Vitro Investigation of Mechanical Parameters Causing Acquired von Willebrand Syndrome in Ventricular Assist Devices
    Egger, Christina
    Maas, Judith
    Hufen, Tristan
    Schmitz-Rode, Thomas
    Steinseifer, Ulrich
    [J]. ARTIFICIAL ORGANS, 2013, 37 (09) : 833 - 839
  • [6] Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
    Federici, AB
    Mazurier, C
    Berntorp, E
    Lee, CA
    Scharrer, I
    Goudemand, J
    Lethagen, S
    Nitu, I
    Ludwig, G
    Hilbert, L
    Mannucci, PM
    [J]. BLOOD, 2004, 103 (06) : 2032 - 2038
  • [7] Current Diagnostic and Therapeutic Approaches to Patients with Acquired von Willebrand Syndrome: A 2013 Update
    Federici, Augusto B.
    Budde, Ulrich
    Castaman, Giancarlo
    Rand, Jacob H.
    Tiede, Andreas
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (02) : 191 - 201
  • [8] Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease
    Geisen, Ulrich
    Heilmann, Claudia
    Beyersdorf, Friedhelm
    Benk, Christoph
    Berchtold-Herz, Michael
    Schlensak, Christian
    Budde, Ulrich
    Zieger, Barbara
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (04) : 679 - 684
  • [9] Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo
    Geisen, Ulrich
    Zieger, Barbara
    Nakamura, Lea
    Weis, Andreas
    Heinz, Juergen
    Michiels, Jan Jacques
    Heilmann, Claudia
    [J]. THROMBOSIS RESEARCH, 2014, 134 (02) : 246 - 250
  • [10] Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation
    Genovese, Elizabeth A.
    Dew, Mary Amanda
    Teuteberg, Jeffrey J.
    Simon, Marc A.
    Kay, Joy
    Siegenthaler, Michael P.
    Bhama, Jay K.
    Bermudez, Christian A.
    Lockard, Kathleen L.
    Winowich, Steve
    Kormos, Robert L.
    [J]. ANNALS OF THORACIC SURGERY, 2009, 88 (04) : 1162 - 1170